News
Ken Frazier on Merck’s COVID Response
Kenneth C. Frazier of Merck was interviewed by Bloomberg Law about the company’s approach to tackling the pandemic and its efforts to develop a COVID-19 vaccine.
Mr. Frazier spoke on prioritization in the distribution of a vaccine—with healthcare workers and high-risk groups being at the top of the list—and the company's commitment to ensuring broad, affordable access when a vaccine does become available.
Read the full piece here.